Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter van der Meer

Showing results (81-90 of 418) with videos related to

Pageof 42
Sort By:
Journal of the American College of Cardiology|July 6, 2004
Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failurePeter van der Meer, Adriaan A Voors, Erik Lipsic, et al.
Stem Cell Reports|November 29, 2013
Functional differences in engineered myocardium from embryonic stem cell-derived versus neonatal cardiomyocytesAdam W Feinberg, Crystal M Ripplinger, Peter van der Meer, et al.
Circulation|January 6, 2010
Endogenous erythropoietin and outcome in heart failureAnne M S Belonje, Adriaan A Voors, Peter van der Meer, et al.
European Journal of Heart Failure|April 26, 2021
Effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on potassium handling in patients with acute heart failureJoost C Beusekamp, Jasper Tromp, Eva M Boorsma, et al.
Circulation. Genomic and Precision Medicine|January 14, 2020
Genetically Determined High Levels of Iron Parameters Are Protective for Coronary Artery DiseaseNiels Grote Beverborg, M Abdullah Said, Haye H van der Wal, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 17, 2015
[Parenteral iron therapy in chronic kidney disease or chronic heart failure]Michele F Eisenga, Adry Diepenbroek, Dorine W Swinkels, et al.
Nature Reviews. Cardiology|September 14, 2023
Immunomodulation and immunopharmacology in heart failureGeorge Markousis-Mavrogenis, Lukas Baumhove, Ali A Al-Mubarak, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 16, 2017
Low circulating microRNA levels in heart failure patients are associated with atherosclerotic disease and cardiovascular-related rehospitalizationsEline L Vegter, Ekaterina S Ovchinnikova, Dirk J van Veldhuisen, et al.
European Journal of Heart Failure|June 8, 2018
Correlation with invasive left ventricular filling pressures and prognostic relevance of the echocardiographic diastolic parameters used in the 2016 ESC heart failure guidelines and in the 2016 ASE/EACVI recommendations: a systematic review in patients with heart failure with preserved ejection fractionJan F Nauta, Yoran M Hummel, Peter van der Meer, et al.
Journal of Internal Medicine|February 9, 2022
Micronutrient deficiencies in heart failure: Mitochondrial dysfunction as a common pathophysiological mechanism?Nils Bomer, Mario G Pavez-Giani, Niels Grote Beverborg, et al.
Pageof 42

Showing results (81-90 of 418) with videos related to

Sort By:
Pageof 42
Journal of the American College of Cardiology|July 6, 2004
Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failurePeter van der Meer, Adriaan A Voors, Erik Lipsic, et al.
Stem Cell Reports|November 29, 2013
Functional differences in engineered myocardium from embryonic stem cell-derived versus neonatal cardiomyocytesAdam W Feinberg, Crystal M Ripplinger, Peter van der Meer, et al.
Circulation|January 6, 2010
Endogenous erythropoietin and outcome in heart failureAnne M S Belonje, Adriaan A Voors, Peter van der Meer, et al.
European Journal of Heart Failure|April 26, 2021
Effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on potassium handling in patients with acute heart failureJoost C Beusekamp, Jasper Tromp, Eva M Boorsma, et al.
Circulation. Genomic and Precision Medicine|January 14, 2020
Genetically Determined High Levels of Iron Parameters Are Protective for Coronary Artery DiseaseNiels Grote Beverborg, M Abdullah Said, Haye H van der Wal, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 17, 2015
[Parenteral iron therapy in chronic kidney disease or chronic heart failure]Michele F Eisenga, Adry Diepenbroek, Dorine W Swinkels, et al.
Nature Reviews. Cardiology|September 14, 2023
Immunomodulation and immunopharmacology in heart failureGeorge Markousis-Mavrogenis, Lukas Baumhove, Ali A Al-Mubarak, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 16, 2017
Low circulating microRNA levels in heart failure patients are associated with atherosclerotic disease and cardiovascular-related rehospitalizationsEline L Vegter, Ekaterina S Ovchinnikova, Dirk J van Veldhuisen, et al.
European Journal of Heart Failure|June 8, 2018
Correlation with invasive left ventricular filling pressures and prognostic relevance of the echocardiographic diastolic parameters used in the 2016 ESC heart failure guidelines and in the 2016 ASE/EACVI recommendations: a systematic review in patients with heart failure with preserved ejection fractionJan F Nauta, Yoran M Hummel, Peter van der Meer, et al.
Journal of Internal Medicine|February 9, 2022
Micronutrient deficiencies in heart failure: Mitochondrial dysfunction as a common pathophysiological mechanism?Nils Bomer, Mario G Pavez-Giani, Niels Grote Beverborg, et al.
Pageof 42